This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Maharsy, W. M Articles by Bikhazi, A. B Search for Related Content PubMed PubMed Citation Articles by Maharsy, W. M Articles by Bikhazi, A. B Social Bookmarking                         What's this?

Cross-talk related to insulin and angiotensin II binding on myocardial remodelling in diabetic rat hearts

Departments of Physiology, American University of Beirut, Beirut, Lebanon

Lina N Kadi

Departments of Physiology, American University of Beirut, Beirut, Lebanon

Nahla G Issa

Departments of Physiology, American University of Beirut, Beirut, Lebanon

Khalil M Bitar

Departments of Physics, American University of Beirut, Beirut, Lebanon

Asdghig H Der-Boghossian

Departments of Physiology, American University of Beirut, Beirut, Lebanon

Roy Abrahamian

Internal Medicine, American University of Beirut, Beirut, Lebanon

Anwar B Bikhazi

Departments of Physiology, American University of Beirut, Beirut, Lebanon, ab04{at}aub.edu.lb

This study focused on the regulation and affinity modulation of angiotensin II (Ang II) binding to its receptor subtypes (AT1- and AT2-receptor) in the coronary endothelium (CE) and cardiomyocytes (CM) of Sprague-Dawley male rats in normal (N), normal treated with losartan (NL), streptozotocin-induced diabetic (D), insulin-treated diabetic (DI), losartan-treated diabetic (DL), and diabetic co-treated with insulin and losartan (DIL). Heart perfusion was used to estimate Ang II binding affinity (=1/k-n) to its receptor subtypes on CE and CM. Diabetes decreased value on CE and increased it on CM as compared to normal. In DL group, the value decreased on CE but was normalised on CM. Insulin treatment alone (DI) or with losartan (DIL) restored to normal on both CE and CM.Western blot results for AT -receptor density showed an increase in diabetics compared to normal with no normalising effect with insulin treatment.The AT1-receptor density was normalised in the diabetic groups treated with losartan +/- insulin. Results for AT₂ receptor regulation revealed a significant difference between untreated (D) and losartan-treated (DL, DIL) diabetic groups.All of these data show the interrelated pathway and cross-talk between insulin and Ang II system indicating potentially negative effects on the diabetic heart.

Key Words: insulin-dependent-diabetes-mellitus • insulin receptor • angiotensin-II receptors • receptor regulation • cardiomyopathy

References

• Clauser E. Synthesis and local and distant actions of vasoactive peptides. Annales d Endocrinologie 2000;61:10-15.[Medline] [Order article via Infotrieve]
• De Mello W., Danser AH Angiotensin II and the heart: on the intracrine renin-angiotensin system. Hypertension 2000;35:1183-8.[Abstract/Free Full Text]
• Kim S., Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000;52(1):11-34.[Abstract/Free Full Text]
• Schwartz F., Duka A., Duka I., Cui J., Gavras H. Novel targets of ANG II regulation in mouse heart identified by serial analysis of gene expression. Am J Physiol Heart Circ Physiol 2004;287:H1957-H1966.[Abstract/Free Full Text]
• Fareh J., Touyz RM, Schiffrin EL, Thibault G. Endothelin-1 and angiotensin II receptors in cells from rat hypertrophied heart. Receptor regulation and intracellular Ca2+ modulation. Circ Res 1996;78:302-11.[Abstract/Free Full Text]
• Clauser E. Molecular structure and function of angiotensin ii receptors. Nephrologie 1998;19:403-10.[Web of Science][Medline] [Order article via Infotrieve]
• Velloso LA, Folli F., Sun XJ, White MF, Saad MJ, Kahn CR Cross-talk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci USA 1996;93:12490-5.[Abstract/Free Full Text]
• Conchon S., Miserey S., Parnot C., Monnot C., Corvol P., Clauser E. Several interesting phenotypes of the AT1 receptor produced by site-directed mutagenesis. J Am Soc Nephrol 1999;10(suppl 11):S8-S14.[Web of Science][Medline] [Order article via Infotrieve]
• Nouet S., Amzallag N., Li JM et al. Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem 2004;279:28989-97.[Abstract/Free Full Text]
• Anavekar NS, Solomon SD Angiotensin II receptor blockade and ventricular remodelling. JRAAS 2005;6(1):43-8.[Medline] [Order article via Infotrieve]
• Ritter O., Schuh K., Brede M., Rothlein N., Burkard N., Hein L., Neyses L. AT2 receptor activation regulates myocardial eNOS expression via the calcineurin-NF-AT pathway. FASEB J 2003;17:283-5.[Abstract/Free Full Text]
• Broxmeyer L. Diabetes mellitus, tuberculosis and the mycobacteria: two millenia of enigma. Med Hypotheses 2005;65:433-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Connelly K., Kelly D., Langham R., Krum H., Gilbert RE Drug therapy for the cardiac complications of diabetes. Drug Discov Today 2004;1:195-200.[CrossRef]
• Sander GE, Wilklow FE, Giles TD Heart failure in diabetes mellitus: causal and treatment considerations. Minerva Cardioangiol 2004;52:491-503.[Medline] [Order article via Infotrieve]
• Sylvia BV Endocrinology and the Heart. In: Crawford MH, editor. Current diagnosis & treatment in cardiology 2nd ed. New York: McGraw Hill;2003 [cited 2007, February 12] available from http://www.accessmedicine.com.
• Al Jaroudi WA, Nuwayri-Salti N., Usta JA Effect of insulin and angiotensin II receptor subtype-1 antagonist on myocardial remodelling in rats with insulin-dependent diabetes mellitus. J Hypertens 2005;23:381-92.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wang P., Almahfouz A., Giorgino F., McCowen K., Smith R. In vivo insulin signaling in the myocardium of streptozotocin-diabetic rats: opposite effects of diabetes on insulin stimulation of glycogen synthase and c-Fos. Endocrinology 1999;140:1141-50.[Abstract/Free Full Text]
• Velloso LA, Folli F., Perego L., Saad MJ The multi-faceted cross-talk between the insulin and angiotensin II signaling systems. Diabetes Metab Res Rev 2006;22:98-107.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Elbaz N., Bedecs K., Masson M., Sutren M., Strosberg AD, Nahmias C. Functional trans-activation of insulin receptor kinase by growth inhibitory angiotensin II AT2 receptor. Mol Endocrinol 2000;14:795-804.[Abstract/Free Full Text]
• Berk BC Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases. J Am Soc Nephrol 1999;10(suppl 11):S62-S68.[Web of Science][Medline] [Order article via Infotrieve]
• Fiordaliso F., Li B., Latini R., Sonnenblick EH, Anversa P., Leri A., Kajstura J. Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II-dependent. Lab Invest 2000;80:513-27.[Web of Science][Medline] [Order article via Infotrieve]
• Karam CN, Nuwayri-Salti N., Usta JA et al. Effect of systemic insulin and angiotensin II receptor subtype-1 antagonist on endothelin-1 receptor subtype(s) regulation and binding in diabetic rat heart. Endothelium 2005;12:225-31.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Masaki T. The discovery of endothelins. Cardiovasc Res 1998;39:530-3.[Free Full Text]
• Teerlink JR Reversal of left ventricular remodeling: role of the endothelin pathway. J Card Fail 2002;8:S494-S499.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• D'Uscio LV, Shaw S., Barton M., Luscher TF Losartan but not verapamil inhibits angiotensin II - induced tissue endothelin-1 increase. Role of blood pressure and endothelial function. Hypertension 1998;31:1305-10.[Abstract/Free Full Text]
• Hopfner RL, McNeill JR, Gopalakrishnan V. Plasma endothelin-1 levels and vascular responses at different temporal stages of streptozotocin diabetes. Eur J Pharmacol 1999;374:221-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Folli F., Kahn R., Hansen H., Bouchie J., Feener P. Angiotensin II inhibits signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J Clin Invest 1997;100:2158-69.[Web of Science][Medline] [Order article via Infotrieve]
• Jiang ZY, Zhou Q., Chatterjee A. et al. Endothelin-1 modulates insulin signaling through phosphatidylinositol 3kinase pathway in vascular smooth muscle cells. Diabetes 1999;48:1120-30.[Abstract]
• Bikhazi AB, Khalifeh AM, Jaroudi WA et al. Endothelin-1 receptor subtypes expression and binding in a perfused rat model of myocardial infarction. Comp Biochem Physiol C Toxicol Pharmacol 2003;134(1):35-43.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Graiani G., Lagrasta C., Migliaccio E. et al. Genetic deletion of the p66Shc adaptor protein protects from angiotensin IIinduced myocardial damage. Hypertension 2005;46:433-40.[Abstract/Free Full Text]
• Sodhi CP, Kanwar YS, Sahai A. Hypoxia and high glucose upregulate AT1-receptor expression and potentiate ANG IIinduced proliferation in VSM cells. Am J Physiol Heart Circ Physiol 2003;284:H846-H852.[Abstract/Free Full Text]
• Wassmann S., Nickenig G. Pathophysiological regulation of the AT1-receptor and implications for vascular disease. J Hypertens 2006;24(1):S15-S21.
• Li C., Cao L., Zeng Q. Astragalus prevents diabetic rats from developing cardiomyopathy by downregulating angiotensin II type 2 receptors' expression. J Huazhong Univ Sci Technolog Med Sci 2004;24:379-84.[Medline] [Order article via Infotrieve]
• Sechi LA, Griffin CA, Schambelan M. The cardiac renin-angiotensin system in STZ-induced diabetes. Diabetes 1994;43:1180-4.[Abstract]
• Amiri F., Garcia R. Renal angiotensin II receptors and protein kinase C in diabetic rats: effects of insulin and ACE inhibition. Am J Physiol Renal Physiol 2000;278:F603-F612.[Abstract/Free Full Text]
• Chen X., Cui Z., Zhang F., Chang W., Chen L., Liu L. Angiotensin II and cAMP regulate AT(1)-mRNA expression in rat cardiomyocytes by transcriptional mechanism. Eur J Pharmacol 2002;448(1):1-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 8, No. 2, 59-65 (2007)
DOI: 10.3317/jraas.2007.011


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Maharsy, W. M Articles by Bikhazi, A. B Search for Related Content PubMed PubMed Citation Articles by Maharsy, W. M Articles by Bikhazi, A. B Social Bookmarking                         What's this?